CAMP FY 2015 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$281M+12.0% YoY

Gross Profit

$103M36.7% margin

Operating Income

$28M10.0% margin

Net Income

$17M6.0% margin

EPS (Diluted)

$0.46

Cash Flow

Operating Cash Flow

$47M

Free Cash Flow

$43M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$384M

Total Liabilities

$195M

Stockholders' Equity

$189M

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$281M	$251M	+12.0%
Gross Profit	$103M	$87M	+17.8%
Operating Income	$28M	$25M	+12.6%
Net Income	$17M	$17M	+2.6%